This escalation phase helps your body adjust to the compound and reduces the risk of side effects like nausea or digestive upset
The impact on participants will depend heavily on where they live, because states set their own eligibility and coverage rules
Important Notice: Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease
Despite the loss of its insulinotropic effect, the GLP-1 products of DPP-4 catalysis exert other actions, such as suppression of hepatic glucose production and antioxidant activity in the cardiovascular system [14]
Table 1 gives a summary of the clinical phase III studies with at least 52 weeks duration on the efficacy of DPP-4 inhibitors compared to sulfonylureas as add on therapy to metformin, respectively, in patients not reaching their glycaemic goals with a monotherapy of metformin